Preliminary Findings from the T1D Exchange COVID-19 Study

Important preliminary findings from the T1D Exchange multi-center surveillance study on people with T1D and COVID-19 were published this week in the Diabetes Care journal.

The research found that about half of the people in the study with Type 1 diabetes and suspected or confirmed COVID-19 infections had abnormally high blood sugar, and nearly 50% developed diabetic ketoacidosis (DKA).

“As we collect additional data, we will be able to provide more insights on factors that contribute to increased risks of hospitalization and adverse outcomes as a result of COVID-19 for people with Type 1 diabetes,” Dr. Osagie Ebekozien, author of the paper and vice president at T1D Exchange, told ABC News.

For people with T1D, the most important takeaways remain similar to those for other viral infections – keep blood sugars monitored and under control, stay hydrated, and communicate with your physicians about sudden changes in your condition.

Sign in or Register to view comments.